FDA approves new oral three-drug regimen for extensively drug-resistant TB
The US Food and Drug Administration (FDA) has approved new oral three-drug regimen for the extensively-drug resistant tuberculosis (XDR-TB). The treatment involves Pretomanid tablets in combination with bedaquiline and linezolid, …
Read More